ConductScience.org, home

Paper34576141

Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors.

Shida Y and 13 others. Int J Mol Sci, 2021. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors. Papers, record 34576141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34576141

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2021-10-19
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shida YYoichi
2Nakazawa TTsutomuhttps://orcid.org/0000-0003-4286-9356
3Matsuda RRyosukehttps://orcid.org/0000-0002-0307-3657
4Morimoto TTakayukihttps://orcid.org/0000-0002-9974-3538
5Nishimura FFumihiko
6Nakamura MMitsutoshihttps://orcid.org/0000-0002-7920-2048
7Maeoka RRyosukehttps://orcid.org/0000-0003-1441-838X
8Yamada SShuichihttps://orcid.org/0000-0002-7278-3978
9Nakagawa IIchirohttps://orcid.org/0000-0002-1340-3293
10Park YSYoung-Soo
11Yasukawa MMotoaki
12Tojo TTakashi
13Tsujimura TTakahiro
14Nakase HHiroyukihttps://orcid.org/0000-0002-2726-5960

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
GlioblastomaMajor topic
Killer Cells, NaturalMajor topic
Lymphocyte ActivationMajor topic
Animals
Apoptosis
B7-H1 Antigen
Cell Line, Tumor
Cell Proliferation
Cytokines
Mice
Mice, Inbred NOD
Mice, SCID
Natural Cytotoxicity Triggering Receptor 1
Programmed Cell Death 1 Receptor
Subcutaneous Tissue
Survival Analysis

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122394507Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.Exp Cell Res2012https://conductscience.org/library/papers/22394507PubMed
228955340The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/28955340PubMed
310684858Differential tumor surveillance by natural killer (NK) and NKT cells.J Exp Med2000https://conductscience.org/library/papers/10684858PubMed
49798907Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG.J Neurochem1998https://conductscience.org/library/papers/9798907PubMed
526323609PD-L1 expression and prognostic impact in glioblastoma.Neuro Oncol2016https://conductscience.org/library/papers/26323609PubMed
627662664PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.Oncotarget2016https://conductscience.org/library/papers/27662664PubMed
77366733Role of NK cells in tumour growth and metastasis in beige mice.Nature1980https://conductscience.org/library/papers/7366733PubMed
815032583The dynamic life of natural killer cells.Annu Rev Immunol2004https://conductscience.org/library/papers/15032583PubMed
922639163Adoptive cell transfer therapy for malignant gliomas.Adv Exp Med Biol2012https://conductscience.org/library/papers/22639163PubMed
1030840664Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.PLoS One2019https://conductscience.org/library/papers/30840664PubMed
1129354116Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.Front Immunol2017https://conductscience.org/library/papers/29354116PubMed
129670929Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.J Immunol1998https://conductscience.org/library/papers/9670929PubMed
139486650HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.Nature1998https://conductscience.org/library/papers/9486650PubMed
1432437507Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/32437507PubMed
1521508954Retro-orbital injections in mice.Lab Anim (NY)2011https://conductscience.org/library/papers/21508954PubMed
1623377437Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.Blood2013https://conductscience.org/library/papers/23377437PubMed
1717100888The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.Immunol Rev2006https://conductscience.org/library/papers/17100888PubMed
1832487617KHYG-1 Cells With EGFRvIII-specific CAR Induced a Pseudoprogression-like Feature in Subcutaneous Tumours Derived from Glioblastoma-like Cells.Anticancer Res2020https://conductscience.org/library/papers/32487617PubMed
1929861604Tumor immunotherapy: New aspects of natural killer cells.Chin J Cancer Res2018https://conductscience.org/library/papers/29861604PubMed
2020536569Effect of NKG2D ligand expression on host immune responses.Immunol Rev2010https://conductscience.org/library/papers/20536569PubMed

See all 52 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42658392⁠From liver to cardiovascular system: the MASLD-ASCVD continuum.Intern Emerg Med2026https://conductscience.org/library/papers/42658392PubMed
42375809Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances.Mil Med Res2026https://conductscience.org/library/papers/42375809PubMed
41601660Natural killer cell-based senotherapy: a promising strategy for healthy aging.Front Immunol2025https://conductscience.org/library/papers/41601660PubMed
41346595Immune checkpoint inhibitors in melanoma: mechanisms, immune cell interactions, and the tumour microenvironment.Front Immunol2025https://conductscience.org/library/papers/41346595PubMed
41144130The microenvironment of glioblastoma: in pursuit of universal multimodal immunotherapy.Acta Neurol Belg2026https://conductscience.org/library/papers/41144130PubMed
38397112Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis.Int J Mol Sci2024https://conductscience.org/library/papers/38397112PubMed
38130720ROS regulation in gliomas: implications for treatment strategies.Front Immunol2023https://conductscience.org/library/papers/38130720PubMed
37841273Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro.Front Immunol2023https://conductscience.org/library/papers/37841273PubMed
37762486
Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom.
Int J Mol Sci2023https://conductscience.org/library/papers/37762486PubMed
37303464An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood.Regen Ther2023https://conductscience.org/library/papers/37303464PubMed
37240104Natural Killer Cells and Immunotherapy.Int J Mol Sci2023https://conductscience.org/library/papers/37240104PubMed
36792722Advances in NK cell therapy for brain tumors.NPJ Precis Oncol2023https://conductscience.org/library/papers/36792722PubMed
36768432Natural Killer Cell-Based Immunotherapy against Glioblastoma.Int J Mol Sci2023https://conductscience.org/library/papers/36768432PubMed
35919498Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors.Regen Ther2022https://conductscience.org/library/papers/35919498PubMed
35203609The War Is on: The Immune System against Glioblastoma-How Can NK Cells Drive This Battle?Biomedicines2022https://conductscience.org/library/papers/35203609PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34576141

GET https://conductscience.org/api/papers/v1/34576141/references?page=2